# A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets

> **NCT01405131** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Therapeutic Equivalency

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT01405131
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01-01
- **Primary completion:** 2012-02-20
- **Final completion:** 2012-02-20
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405131, "A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01405131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*